Ekso Bionics Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation - Schedule of Stock-based Compensation Expense Related to Stock Options and RSUs Granted to Employees and Non-employees (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 2,255	$ 2,868
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	653	611
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	241	426
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 1,361	$ 1,831